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Despite a nUIIlber of studies, the etiology of keloids 
reIIlains unknown. We have investigated the response 
of fibroblasts derived froIIl keloid tissue and norIIlal 
adult skin to platelet-derived growth factor (PDGF), 
epiderIIlal growth factor (EGF), and fibroblast growth 
factor (FGF). Keloid fibroblasts were IIlore responsive 
in both cheIIlotactic and IIlitogenic assays to all three 
isoforIIls ofPDGF than fibroblasts froIIl norIIlal skin. 
A major connective tissue cell growth factor present in serum and platelets is platelet derived growth factor (PDGF) . PDGF is an interchain disulfide-bonded di-me ric protein, consisting of homologous polypeptide chains denoted A and B (AA, AB, and BB) that is 
mitogenic and chemotactic for connective tissue cells [1-6]. PDGF 
also stimulates collagenase production [7], and synthesis of extracel-
lular matrix components such as fibronectin [8] and hyaluronic acid 
[9]. The biologic and biochemical actions ofPDGF are mediated by 
specific cell surface receptors. Currently, two types ofPDGF recep-
tors (types 0' and {J) have been identified and cloned [10-14]. Both 
of these receptors exhibit tyrosine kinase activity and are autophos-
phorylated upon activation with PDGF. These receptors exhibit 
differential ligand binding specificities for the three PDGF isoforms 
(AA, AB, BB). The type 0' receptor binds all three isoforms and the 
type P receptor binds the BB isoform with high affinity [15] and the 
AB isoform in certain cell types [16,17]. Thus, the types and 
amounts of PDGF receptors present on a connective tissue cell de-
termine the cell's responsivity to the various PDGF isoforms 
[16-19]. 
While various types of cells have been reported to produce 
PDGF, the most abundant natural source of these peptides is plate-
lets. Because of the multiple biologic actions of this peptide and the 
role of platelets in the early response to injury it is believed that the 
primary biologic function of PDGF is that of a wound hormone 
[20]. In addition to this action in n9rmal repair PDGF is also be-
lieved to playa central role in variQus pathologic states including 
fibrotic disorders such as atherosclerosis [21] and certain cancers 
[22]. 
To investigate the potential role of PDGF and other growth 
factors in keloid formation we compared the response of fibroblasts 
derived from keloid tissue with that of fibroblasts isolated in an 
identical manner from normal human skin to PDGF, epidermal 
growth factor (EGF), and fibroblast growth factor (FGF). We found 
Manuscript received February 3, 1994; accepted for publication May 16, 
1994. 
Reprint requests to: Gary R. Grotendorst, Department of Cell Biology 
and Anatomy (R-124), University of Miami School of Medicine, 1600 NW 
10th Avenue, Miami, FL 33136. 
No enhanced response of the cells to either EGF or FGF 
was detected. The euhanced PDGF response of keloid 
fibroblasts appears to be IIlediated by elevated levels of 
PDGF O! receptors, which are 4 - 5 tiIIles higher than 
those in nor lIla I hUIIlan skin fibroblasts. Key words: 
platelet-derived growth factor/ epidermal growth factor/fi-
broblastgrowthfactor.] Invest DermatoI103:560-563, 1994 
that the keloid cells were more responsive than the normal cells to 
PDGF. No difference was detected in the response between the two 
cell types to EGF or FGF. The elevated response of the keloid 
fibroblasts to PDGF could be accollnted for by elevated levels of 
PDGF 0' receptor. 
MATERIALS AND METHODS 
Culture of Fibroblasts Eight strains of keloid fibroblasts were grown 
from different keloid tissue obtained from five individuals. Patients were all 
black, four were female, and one was male. Patient ages ranged from 16 to 48 
years. Five of eight keloids were located at the ear lobe, with the others at the 
neck. Normal skin tissue samples were obtained from age-, race-, and sex-
matched volunteer donors from forearm punch biopsy. All tissue specimellS, 
eight keloid and four normal adult dermis, were obtained from the Depart-
ment of Dermatology, University of Miami, Miami, Florida. The lesions 
were diagnosed as keloids on the basis of clinical appearance, persistency, and 
extension beyond the original wound margins. Specimens were obtained by 
surgical removal under local anesthesia after informed consent was obtained. 
Epidermis and subepidermal fat were removed from tissue and minced speci-
mens (1-2 mm3) were placed on 100-mm tissue culture plates. Explams 
were cultured using Dulbecco's modified Eagle's medium (DMEM, 4.5 gil 
glucose) supplemented with 10% fetal bovine serum (FBS, Hyclone Labora-
tories Inc., Logan, UT), 5 )lg/ ml Gentamicin (Quality Biological, Inc., 
Gaithersburg, MD) at 37"C, in an atmosphere of 10% CO2 and 90% air. 
Cells were passed at confluence by trypsin/ethylenediaminetetraacetic acid 
treatment and used in this investigation at passages 3 to 5. During these 
experiments, cultures showed no evidence of crisis or senescence. 
Mitogenic, Chemotactic, and PDGF Receptor Assays Mitogenic 
assays were performed with confluent cultures of cells. Culture medium was 
changed to DMEM with 2.5% FBS 24 h before addition of growth factors . 
DNA synthesis was determined as described previously [23]. Chemotactic 
assays were performed using modified Boyden chambers on confluent cul-
tures as described previously [23,24]. 
Tyrosine autophosphorylation of PDGF receptors was determined using 
confluent cultures of cells as described previously [16]. Briefly, cells were 
treated for 30 min at 37°C with 20 ng/ 1111 PDGF, the membranes isolated, 
and the receptors extracted. The receptor extract was analyzed on sodium 
dodecyl sulfate (SDS) polyacrylamide gels and Western blots with an anti-
phosphotyrosine monoclonal antibody (PY -60, ICN). 
RESULTS 
Mitogenic Response of Normal and Keloid Fibroblasts Ini-
tially, we compared the mitogenic response of the eight keloid and 
0022-202X/94 /S07 .00 Copyright © 1994 by The Society for Investigative Dermatology, Ina. 
560 
VOL. 103, NO. 4 OCTOBER 1994 
6 
r: 
a 
:;; 
c 
"5 ... 
E 
i}j 
"C 
"0 
"- 2 
0 
20 
r: 
c 
15 :;; c 
"5 
E 
:;; 
'" 
10 
"C 
~ 
5 
0 
20 
5 15 
:;; 
c 
"5 
Jj 10 
'" 
0 5 
0 5 
MITOGENIC ACTMTY 
Keloid Fibroblasts 
.,y.. 
Normal Skin Fibroblasts 
PDGF M (ng/ml) 
10 15 20 
Keloid Fibroblasts 
. .. · .... 0 · .... · .... ~ 
Normal Skin Fibroblasts 
PDGF AS (ng/mll 
10 15 
Keloid Fib roblasts 
20 
... ~ 
Normal Skin Fibroblasts 
PDGF 88 (ng/mll 
OL-------~------~--------~------~--~ 
o 5 10 15 20 
Figure 1. PDGF induced DNA synthesis of keloid and normal fibro-
blasts. Keloid fibroblasts exhibited significantly greater stimulation of 
DNA synthesis in response to all forms of PDGF than normal skin fibro-
blasts. The data represent the mean values of the fo ld stimulation of DNA 
synthesis by PDGF in the eight keloid and four normal skin fibroblast 
cultures. A significant (p < 0.01, two-tailed Student t test) difference in 
mitogenic response was obtained with 2.5-20 ngl ml ofPDGF AA and An 
and at 20 ngl ml PDGF BE. 
four normal fibroblast cultures to the three POGF isoforms (Fig 1). 
The normal fibroblasts responded to POGF AB and BB, with a dose 
response curve of 0.5-20 ng/ml POGF and a concentration of 
5 -10 ng/ml eliciting a maximal response. In comparison, POGF 
AA was weakly active on these cells and stimulated less than a 
twofold increase in DNA synthesis over non-treated control levels. 
This is consistent with previous studies on various human fibro-
blasts [16-18] . In marked contrast, the POGF AB and BB response 
of keloid fibroblasts was approximately twice that of normalfibro-
blasts, indicating that keloid fibroblasts are more responsive to 
PDGF than normal fibrob lasts. The enhanced response of keloid 
fibroblasts was more pronounced to PDGF AA where the keloid-
derived cells exhibited a nearly sixfold stimulation of D N A synthe-
sis. The elevated response to POGF by the keloid cells was not 
paralleled by an increased response to other growth factors. Basic 
FGF was equally active on both normal and keloid cells and the 
keloid cells were much less responsive to EGF than the normals 
(Fig 2). The diminished response to EGF is a property that had been 
observed previously in keloid-derived fibroblasts by Russell and 
coworkers [25]. These data demonstrate that the enhanced response 
to keloids is not due to a general increase in growth response to any 
growth factor but is limited to the action of POGF. 
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Figure 2. EGF- and FGF-induced DNA synthesis of keloid and nor-
mal fibroblasts. Parallel cultures to those used in Fig 1 were tested for a 
mitogenic response to A) EGF and B) FGF. The data arc representative of 
the mitogenic response of the cells to each of these factors. These studies 
were repeated 4 times using different cells that exhibited a similar pattern of 
response to EGF and FGF. 
Chemotactic Response of Normal and Keloid Fibroblasts 
Next we investigated the chemotactic ac tivity of the PDGF iso-
forms on keloid and normal fibroblasts using the Boyden chamber 
assay (Fig 3). Both keloid and normal fibroblasts migrated toward 
POGF in a dose-dependent manner. The results of these studies 
were similar to those of the mitogenic response to POGF. Fibro-
blasts isolated from normal skin responded strongly to PDGF AB 
and BB but weakly to PDGF AA. In contrast, the keloid cells re-
sponded well to all three isoforms of POGF and exhibited a nearly 
threefold greater migratory response to equivalent amounts of 
POGF than the normal cells. 
PDGF Receptor Content and Activation in Norm.al and Ke-
loid Fibroblasts POGF mediates its biologic action via specific 
cell surface receptors and, as discussed above, two distinct PDGF 
receptors (types ex and fJ) that exhibit differential li gand binding 
have been identified. Because of the enhanced responsiveness of the 
cells to POGF we wanted to determine whether there was an alter-
ation in the relative levels of the POGF ex and jJ receptors present on 
the keloid fibroblasts compared to the cells cultured from normal 
skin. Cell extracts from equivalent amounts of cells were prepared 
and analyzed by Western blotting using either PDGF-ex-receptor-
or POGF-fJ-receptor-specific antiserum (Fig 4A). Both cell types 
contained nearly equivalent amounts of PDGF fJ receptor based on 
the amount detected in the Western blot. However, the keloid 
fibrobl as ts contained a 4- 5 times increase in the amount ofpOGF ex 
receptors compared to the normal fibrob lasts . 
W e next examined the functional activity of the POGF ex recep-
tors present on both normal and keloid fibrobl asts using tyrosine 
autophosphorylation as a measure of receptor activation. Confluent 
cu ltures of fibroblasts were incubated with 20 ng/ ml of one of the 
POGF isoforms for 10 min at 37"C and the membrane fra ction 
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Figure 3. Chemotactic response of keloid and normal dermal fibro-
blasts to PDGF. Keloid fibroblasts exhibited a greater migratory response 
to all th ree isoforms ofPDGF than normal fibroblasts. The data represent the 
mean v.al ues of the chemotactic response of the eight keloid and four normal 
skin fibroblast cultures to PDGF. A significant (p < 0.01, two-tailed Student 
t test) difference in mitogenic response was obtained at all concentrations 
and isoforms of PDGF tested. 
extracted. The PDGF a receptor was immunoprecipitated and ana-
lyzed by Western blot using a specific anti-phosphotyrosine mono-
clonal antibody (Fig 4B). All three isoforms stimulated a large 
increase in the tyrosine autophosphorylation of the PDGF a recep-
tor on the keloid fibroblasts . However, no detectable tyrosine auto-
phosphorylation was observed in the normal fibroblasts at equal 
concentrations of PDGF and cells. These results confirm our bio-
logic assays and demonstrate that the elevated response of the keloid 
cells to PDGF is due to an increase in the number of functional 
PDGF a receptors present. Because the PDGF a receptor is acti-
vated equally well by all three isoforms of PDGF, it alone can 
account for the enhanced responsiveness of the keloid cells to all 
isoforms of PDGF. The PDGF P receptor is activated solely by 
PDGF BB and all elevation in this type of receptor would not 
account for the enhanced AB and AA response we have detected in 
the keloid cells. 
DISCUSSION 
These data strongly suggest that the fibroblasts present in keloid 
ti ssue are a different population from those present in normal 
dermis. Although it is possible that the cells we are studying in 
culture have been altered from those residing in the tissue by place-
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ment in tissue culture [26]. the keloid-derived cells maintain a phe-
notype distinct from that of fibroblasts derived from normal skin 
cultured under identical conditions . Furthermore, this phenotype is 
maintained after multiple cell divisions long after removal from the 
in vivo environment, indicating that the differences we have de-
tected are not due to a temporary change induced by some cytokille 
or other environmental parameter unique to the keloid site. 
Past studies have reported other phenotypic differences between 
keloid and normal fibroblasts, including increased deposition of 
extracellular matrix components such as collagen, fibronectin, and 
chondroitin sulfate proteoglycan in keloid tissue and in keloid fi-
broblast cultures [27 - 31]. In addition to enhanced matrix synthesis, 
hypercellularity of keloid lesions has also been reported based on 
quantitative histopathologic examination and chemical determina-
tion of DNA content [32]. However, in contrast to the irl villo 
observations of hyper cellularity of keloid tissue, previous studies on 
the growth characteristics of the fibroblasts isolated from keloids 
have found them similar to those of normal fibroblasts under stan-
dard culture conditions [25,32]. We could not detect any significant 
difference in the mean population doubling time, cell density at 
confluence, or cellular volume of the keloid fibroblasts used in this 
study compared to the normal skin fibrob lasts when grown in 
DMEM containing 10% fetal bovine serum. Our finding that ke-
loid fibroblasts are more responsive to PDGF than normal skin 
fibroblasts is the first reported enhanced growth factor response by 
keloid fibroblasts. 
Altered phenotypes of fibroblastic cells have been implicated in 
other fibrotic diseases including atherosclerosis . Benditt has sug-
gested that the atherosclerotic plaque is similar to a benign tumor 
and has found that the cells present in plaques appear to be derived 
from a single cell based on genetic analysis of X-linked genes in 
atherosclerotic plaques obtained from heterozygotic females [33] . 
Two potential mechanisms for the generation of such a cell popula-
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Figure 4. Type a and P PDGF receptors on keloid and normal fibro-
blasts. A) Total amounts of types a and pPDGF receptors. Immunoprecipi-
tates prepared from equivalent numbers of cells were analyzed by W estern 
blot. La/Ie N, extracts from normal skin fibroblasts; /a/Je K, from keloid 
fibroblasts. Fibroblasts from kcloids contained a 4 - 5 times higher amount of 
PDGF a receptors than those in normal skin. The number of PDGF P 
receptors was nearly equal in both cell types. B) Autophosphorylation of 
PDGF ex receptors by PDGF. Immunoprecipitatcs were prepared from 
equivalent numbers of the cells from both keloid and normal fibroblast 
cultures. La/Je C, no PDGF added; AA, 20 ngj mI ofPDGF AA hotnodimer; 
AB, 20 ngj ml of PDGF AB heterodimer; BB, 20 ngj mI of PDGF BB 
homodimer. Keloid fibroblasts exhibited a high level of autophosphoryla-
tion of the PDGF a receptor induced by all PDGF isoforms, whereas normal 
skin fibroblasts exhibited no detectable autophosphorylation under the same 
conditions. 
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tion are the transformation of a single cell that replicates to form the 
lesion or the selective recruitment of a subpopulation of fibroblasts 
that preferentially responds to an environmental factor present at 
the site of lesion formation. It is also possible that a combination of 
these two events leads to the fibrotic state. 
Keloid formation occurs exclusively at sites of trauma and in areas 
of the body associated with increased tension and motion of the 
skin, such as joints [34]. Whereas no overt trauma has occurred in 
the areas of repeated skin stretching, microvessel occlusion has been 
observed at these sites and in keloids [35], which would indicate 
platelet aggregation and release of PDGF. These phenomena, cou-
pled with an elevated response of fibroblasts in the tissue to PDGF, 
could lead to the formation of the keloid. 
The keloid fibroblasts responded well to PDGF AA, whereas 
normal skin fibroblasts responded poorly to PDGF AA. This may 
prove to be one of the most important differences between the 
keloid and normal fibroblasts. We have recently reported that the 
predominant PDGF isoform present in human platelets and acute 
human wound fluid is PDGF AA [36,37]. Thus, platelet aggrega-
tion and release ofPDGF at a site of trauma supplies a growth factor 
that is potent for the keloid-lesion-derived fibroblast but not those 
present in the normal skin cultures . The elevated levels of PDGF a 
receptor in the keloid fibroblasts present in the keloid-derived cells 
W"ould make them much more responsive to PDGF AA as a che-
moattractant and mitogen. The presence of PDGF AA in the tissue 
could selectively recruit cells with elevated PDGF a receptors, 
forming a site with a distinct subpopulation of fibroblasts. Subse-
quent incidents of trauma that release more PDGF AA at this site 
W"ould amplify these differences and support the overgrowth of 
these cells. 
Studies examining the expression of PDGF receptors in wounds 
have found an elevation of the PDGF P receptor compared to non-
injured dermis in both chronic wounds [38] and normal healing 
W"ounds [39]. No increases in PDGF a receptors have been reported. 
In addition, active lesions of systemic sclerosis [40) and psoriasis (38) 
are populated by connective tissue cells, expressing elevated levels 
of PDGF P receptors . These data suggest that the elevation of 
PDGF a receptors may not be a common phenomena for activation 
of dermal fibrotic lesions and that in normal wound healing the 
PDGF a receptors may not be elevated. Thus, the increased expres-
sion ofPDGF a receptors may be unique to keloids. Whether these 
cells represent a normal subpopulation of dermal fibroblasts or are 
the result of transformation remains to be determined. 
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